These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 14575836

  • 1. Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response.
    Horsman MR, Murata R.
    Int J Radiat Oncol Biol Phys; 2003 Nov 15; 57(4):1047-55. PubMed ID: 14575836
    [Abstract] [Full Text] [Related]

  • 2. Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors.
    Murata R, Siemann DW, Overgaard J, Horsman MR.
    Radiother Oncol; 2001 Aug 15; 60(2):155-61. PubMed ID: 11439210
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of radiation therapy by the novel vascular targeting agent ZD6126.
    Siemann DW, Rojiani AM.
    Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):164-71. PubMed ID: 12007956
    [Abstract] [Full Text] [Related]

  • 4. Antitumor efficacy of conventional anticancer drugs is enhanced by the vascular targeting agent ZD6126.
    Siemann DW, Rojiani AM.
    Int J Radiat Oncol Biol Phys; 2002 Dec 01; 54(5):1512-7. PubMed ID: 12459379
    [Abstract] [Full Text] [Related]

  • 5. The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors.
    Siemann DW, Rojiani AM.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):846-53. PubMed ID: 15936569
    [Abstract] [Full Text] [Related]

  • 6. The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors.
    Horsman MR, Ehrnrooth E, Ladekarl M, Overgaard J.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):895-8. PubMed ID: 9845117
    [Abstract] [Full Text] [Related]

  • 7. Combination of vascular targeting agents with thermal or radiation therapy.
    Horsman MR, Murata R.
    Int J Radiat Oncol Biol Phys; 2002 Dec 01; 54(5):1518-23. PubMed ID: 12459380
    [Abstract] [Full Text] [Related]

  • 8. Augmentation of radiation response with the vascular targeting agent ZD6126.
    Hoang T, Huang S, Armstrong E, Eickhoff JC, Harari PM.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1458-65. PubMed ID: 16488554
    [Abstract] [Full Text] [Related]

  • 9. The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: a comparative assessment using MRI and MRS.
    Breidahl T, Nielsen FU, Stødkilde-Jørgensen H, Maxwell RJ, Horsman MR.
    Acta Oncol; 2006 Apr 01; 45(3):306-16. PubMed ID: 16644574
    [Abstract] [Full Text] [Related]

  • 10. Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.
    Murata R, Overgaard J, Horsman MR.
    Int J Radiat Oncol Biol Phys; 2001 Nov 15; 51(4):1018-24. PubMed ID: 11704326
    [Abstract] [Full Text] [Related]

  • 11. Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
    Murata R, Siemann DW, Overgaard J, Horsman MR.
    Radiat Res; 2001 Nov 15; 156(5 Pt 1):503-9. PubMed ID: 11604063
    [Abstract] [Full Text] [Related]

  • 12. Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R, Overgaard J, Horsman MR.
    Int J Hyperthermia; 2001 Nov 15; 17(6):508-19. PubMed ID: 11719967
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR, Overgaard J.
    Radiother Oncol; 2004 Mar 15; 70(3):301-9. PubMed ID: 15064017
    [Abstract] [Full Text] [Related]

  • 17. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
    Horsman MR, Nielsen T, Østergaard L, Overgaard J.
    Acta Oncol; 2006 Mar 15; 45(7):876-80. PubMed ID: 16982553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma.
    Horsman MR, Overgaard J.
    Radiother Oncol; 1992 Sep 15; 25(1):43-8. PubMed ID: 1410589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.